Proactiveinvestors USA & Canada Zynerba Pharmaceuticals https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Zynerba Pharmaceuticals RSS feed en Mon, 16 Sep 2019 09:13:48 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - NA Proactive news snapshot: Bonterra Resources, Global Atomic Corporation, Harvest One Cannabis UPDATE … ]]> https://www.proactiveinvestors.com/companies/news/902140/na-proactive-news-snapshot-bonterra-resources-global-atomic-corporation-harvest-one-cannabis-update--902140.html Thu, 05 Sep 2019 12:55:00 -0400 https://www.proactiveinvestors.com/companies/news/902140/na-proactive-news-snapshot-bonterra-resources-global-atomic-corporation-harvest-one-cannabis-update--902140.html <![CDATA[News - Zynerba shares evidence that CBD may be effective in managing constellation of sociobehavioral symptoms ]]> https://www.proactiveinvestors.com/companies/news/902128/zynerba-shares-evidence-that-cbd-may-be-effective-in-managing-constellation-of-sociobehavioral-symptoms-902128.html Thu, 05 Sep 2019 09:30:00 -0400 https://www.proactiveinvestors.com/companies/news/902128/zynerba-shares-evidence-that-cbd-may-be-effective-in-managing-constellation-of-sociobehavioral-symptoms-902128.html <![CDATA[News - NA Proactive news snapshot: LeanLife Health, Phunware, Biome Grow, ImmunoPrecise Antibodies, GrapheneCA ... ]]> https://www.proactiveinvestors.com/companies/news/901736/na-proactive-news-snapshot-leanlife-health-phunware-biome-grow-immunoprecise-antibodies-grapheneca--901736.html Thu, 29 Aug 2019 10:00:00 -0400 https://www.proactiveinvestors.com/companies/news/901736/na-proactive-news-snapshot-leanlife-health-phunware-biome-grow-immunoprecise-antibodies-grapheneca--901736.html <![CDATA[News - Zynerba boosts cash position in 2Q, gears up for top-line data from key trials with Zygel CBD gel ]]> https://www.proactiveinvestors.com/companies/news/900227/zynerba-boosts-cash-position-in-2q-gears-up-for-top-line-data-from-key-trials-with-zygel-cbd-gel-900227.html Tue, 06 Aug 2019 10:50:00 -0400 https://www.proactiveinvestors.com/companies/news/900227/zynerba-boosts-cash-position-in-2q-gears-up-for-top-line-data-from-key-trials-with-zygel-cbd-gel-900227.html <![CDATA[News - NA Proactive news snapshot: Cannvas MedTech, RYAH Medtech, Constantine Metal Resources, Bragg Gaming Group … ]]> https://www.proactiveinvestors.com/companies/news/224809/na-proactive-news-snapshot-cannvas-medtech-ryah-medtech-constantine-metal-resources-bragg-gaming-group--224809.html Wed, 31 Jul 2019 11:10:00 -0400 https://www.proactiveinvestors.com/companies/news/224809/na-proactive-news-snapshot-cannvas-medtech-ryah-medtech-constantine-metal-resources-bragg-gaming-group--224809.html <![CDATA[News - Zynerba Pharmaceuticals joins Russell 3000 and Russell 2000 indexes ]]> https://www.proactiveinvestors.com/companies/news/223145/zynerba-pharmaceuticals-joins-russell-3000-and-russell-2000-indexes-223145.html Mon, 01 Jul 2019 08:59:00 -0400 https://www.proactiveinvestors.com/companies/news/223145/zynerba-pharmaceuticals-joins-russell-3000-and-russell-2000-indexes-223145.html <![CDATA[News - Zynerba wins new US patent for treatment of Autism Spectrum Disorder with CBD ]]> https://www.proactiveinvestors.com/companies/news/221882/zynerba-wins-new-us-patent-for-treatment-of-autism-spectrum-disorder-with-cbd-221882.html Tue, 11 Jun 2019 07:50:00 -0400 https://www.proactiveinvestors.com/companies/news/221882/zynerba-wins-new-us-patent-for-treatment-of-autism-spectrum-disorder-with-cbd-221882.html <![CDATA[News - Zynerba tells FDA it should regulate CBD and cannabis-derived products like standard pharmaceuticals ]]> https://www.proactiveinvestors.com/companies/news/221313/zynerba-tells-fda-it-should-regulate-cbd-and-cannabis-derived-products-like-standard-pharmaceuticals-221313.html Fri, 31 May 2019 09:09:00 -0400 https://www.proactiveinvestors.com/companies/news/221313/zynerba-tells-fda-it-should-regulate-cbd-and-cannabis-derived-products-like-standard-pharmaceuticals-221313.html <![CDATA[News - Zynerba launches the Phase 2 trial of its Zygel CBD gel to treat 22q genetic condition ]]> https://www.proactiveinvestors.com/companies/news/221134/zynerba-launches-the-phase-2-trial-of-its-zygel-cbd-gel-to-treat-22q-genetic-condition-221134.html Wed, 29 May 2019 12:35:00 -0400 https://www.proactiveinvestors.com/companies/news/221134/zynerba-launches-the-phase-2-trial-of-its-zygel-cbd-gel-to-treat-22q-genetic-condition-221134.html <![CDATA[News - Zynerba boosts cash position in 1Q, gears up for top-line data from four key trials with Zygel CBD gel ]]> https://www.proactiveinvestors.com/companies/news/219890/zynerba-boosts-cash-position-in-1q-gears-up-for-top-line-data-from-four-key-trials-with-zygel-cbd-gel-219890.html Wed, 08 May 2019 08:43:00 -0400 https://www.proactiveinvestors.com/companies/news/219890/zynerba-boosts-cash-position-in-1q-gears-up-for-top-line-data-from-four-key-trials-with-zygel-cbd-gel-219890.html <![CDATA[News - Small-Cap Snapshot: Zynerba earns FDA Fast Track designation; Fred's falls on fiscal 4Q results, store closings ]]> https://www.proactiveinvestors.com/companies/news/219731/small-cap-snapshot-zynerba-earns-fda-fast-track-designation-fred-s-falls-on-fiscal-4q-results-store-closings-219731.html Mon, 06 May 2019 11:55:00 -0400 https://www.proactiveinvestors.com/companies/news/219731/small-cap-snapshot-zynerba-earns-fda-fast-track-designation-fred-s-falls-on-fiscal-4q-results-store-closings-219731.html <![CDATA[News - Zynerba Pharmaceuticals scores Fast Track FDA designation for Zygel CBD gel ]]> https://www.proactiveinvestors.com/companies/news/219715/zynerba-pharmaceuticals-scores-fast-track-fda-designation-for-zygel-cbd-gel-219715.html Mon, 06 May 2019 07:33:00 -0400 https://www.proactiveinvestors.com/companies/news/219715/zynerba-pharmaceuticals-scores-fast-track-fda-designation-for-zygel-cbd-gel-219715.html <![CDATA[News - Zynerba rockets as investors await CEO's presentation at London conference ]]> https://www.proactiveinvestors.com/companies/news/217900/zynerba-rockets-as-investors-await-ceo-s-presentation-at-london-conference-217900.html Wed, 03 Apr 2019 13:50:00 -0400 https://www.proactiveinvestors.com/companies/news/217900/zynerba-rockets-as-investors-await-ceo-s-presentation-at-london-conference-217900.html <![CDATA[News - Zynerba Pharmaceuticals well-funded for its CBD clinical trials into 2021 ]]> https://www.proactiveinvestors.com/companies/news/312575/zynerba-pharmaceuticals-well-funded-for-its-cbd-clinical-trials-into-2021-12575.html Tue, 12 Mar 2019 13:24:00 -0400 https://www.proactiveinvestors.com/companies/news/312575/zynerba-pharmaceuticals-well-funded-for-its-cbd-clinical-trials-into-2021-12575.html <![CDATA[News - Zynerba’s 4Q shows momentum as it heads into key clinical trial ]]> https://www.proactiveinvestors.com/companies/news/216216/zynerbas-4q-shows-momentum-as-it-heads-into-key-clinical-trial-216216.html Mon, 11 Mar 2019 13:19:00 -0400 https://www.proactiveinvestors.com/companies/news/216216/zynerbas-4q-shows-momentum-as-it-heads-into-key-clinical-trial-216216.html <![CDATA[News - Zynerba Pharmaceuticals launches Phase 2 trial of Zygel in autism spectrum disorder ]]> https://www.proactiveinvestors.com/companies/news/216010/zynerba-pharmaceuticals-launches-phase-2-trial-of-zygel-in-autism-spectrum-disorder-216010.html Thu, 07 Mar 2019 07:40:00 -0500 https://www.proactiveinvestors.com/companies/news/216010/zynerba-pharmaceuticals-launches-phase-2-trial-of-zygel-in-autism-spectrum-disorder-216010.html <![CDATA[News - Zynerba Pharmaceuticals receives new US patent for treatment of Fragile X syndrome with CBD ]]> https://www.proactiveinvestors.com/companies/news/215326/zynerba-pharmaceuticals-receives-new-us-patent-for-treatment-of-fragile-x-syndrome-with-cbd-215326.html Tue, 26 Feb 2019 07:49:00 -0500 https://www.proactiveinvestors.com/companies/news/215326/zynerba-pharmaceuticals-receives-new-us-patent-for-treatment-of-fragile-x-syndrome-with-cbd-215326.html <![CDATA[News - Zynerba Pharmaceuticals’ quest for CBD gel to treat Fragile X syndrome ventures where big pharma fears to tread ]]> https://www.proactiveinvestors.com/companies/news/215151/zynerba-pharmaceuticals-quest-for-cbd-gel-to-treat-fragile-x-syndrome-ventures-where-big-pharma-fears-to-tread-215151.html Fri, 22 Feb 2019 10:19:00 -0500 https://www.proactiveinvestors.com/companies/news/215151/zynerba-pharmaceuticals-quest-for-cbd-gel-to-treat-fragile-x-syndrome-ventures-where-big-pharma-fears-to-tread-215151.html <![CDATA[News - Zynerba Pharmaceuticals adds pharma exec to its board ]]> https://www.proactiveinvestors.com/companies/news/214974/zynerba-pharmaceuticals-adds-pharma-exec-to-its-board-214974.html Wed, 20 Feb 2019 08:56:00 -0500 https://www.proactiveinvestors.com/companies/news/214974/zynerba-pharmaceuticals-adds-pharma-exec-to-its-board-214974.html <![CDATA[News - Zynerba updates on its two clinical CBD studies ]]> https://www.proactiveinvestors.com/companies/news/312172/zynerba-updates-on-its-two-clinical-cbd-studies-12172.html Mon, 11 Feb 2019 17:05:00 -0500 https://www.proactiveinvestors.com/companies/news/312172/zynerba-updates-on-its-two-clinical-cbd-studies-12172.html <![CDATA[News - Proactive Investors cannabis conference in New York showcases industry potential for investors ]]> https://www.proactiveinvestors.com/companies/news/213750/proactive-investors-cannabis-conference-in-new-york-showcases-industry-potential-for-investors-213750.html Thu, 31 Jan 2019 10:40:00 -0500 https://www.proactiveinvestors.com/companies/news/213750/proactive-investors-cannabis-conference-in-new-york-showcases-industry-potential-for-investors-213750.html <![CDATA[News - Proactive Investors conference in New York focuses on small-cap cannabis industry ]]> https://www.proactiveinvestors.com/companies/news/213639/proactive-investors-conference-in-new-york-focuses-on-small-cap-cannabis-industry-213639.html Wed, 30 Jan 2019 10:52:00 -0500 https://www.proactiveinvestors.com/companies/news/213639/proactive-investors-conference-in-new-york-focuses-on-small-cap-cannabis-industry-213639.html <![CDATA[News - Zynerba Pharmaceuticals stock soars amid slew of positive drivers ]]> https://www.proactiveinvestors.com/companies/news/213552/zynerba-pharmaceuticals-stock-soars-amid-slew-of-positive-drivers-213552.html Tue, 29 Jan 2019 15:22:00 -0500 https://www.proactiveinvestors.com/companies/news/213552/zynerba-pharmaceuticals-stock-soars-amid-slew-of-positive-drivers-213552.html <![CDATA[News - SCYNEXIS names Zynerba CEO Armando Anido to its board ]]> https://www.proactiveinvestors.com/companies/news/213086/scynexis-names-zynerba-ceo-armando-anido-to-its-board-213086.html Tue, 22 Jan 2019 09:52:00 -0500 https://www.proactiveinvestors.com/companies/news/213086/scynexis-names-zynerba-ceo-armando-anido-to-its-board-213086.html <![CDATA[News - Zynerba on track to report cannabidiol gel treatment results for Fragile X childhood disorder ]]> https://www.proactiveinvestors.com/companies/news/211523/zynerba-on-track-to-report-cannabidiol-gel-treatment-results-for-fragile-x-childhood-disorder-211523.html Wed, 19 Dec 2018 13:57:00 -0500 https://www.proactiveinvestors.com/companies/news/211523/zynerba-on-track-to-report-cannabidiol-gel-treatment-results-for-fragile-x-childhood-disorder-211523.html <![CDATA[News - Zynerba Pharmaceuticals CEO welcomes FDA approval of cannabinoid products ]]> https://www.proactiveinvestors.com/companies/news/208544/zynerba-pharmaceuticals-ceo-welcomes-fda-approval-of-cannabinoid-products-208544.html Mon, 05 Nov 2018 10:44:00 -0500 https://www.proactiveinvestors.com/companies/news/208544/zynerba-pharmaceuticals-ceo-welcomes-fda-approval-of-cannabinoid-products-208544.html <![CDATA[News - Zynerba Pharmaceuticals anticipates data in late 2019 for its phase 3 cannabinoid drug ]]> https://www.proactiveinvestors.com/companies/news/310912/zynerba-pharmaceuticals-anticipates-data-in-late-2019-for-its-phase-3-cannabinoid-drug-10912.html Thu, 18 Oct 2018 11:30:00 -0400 https://www.proactiveinvestors.com/companies/news/310912/zynerba-pharmaceuticals-anticipates-data-in-late-2019-for-its-phase-3-cannabinoid-drug-10912.html <![CDATA[News - Are marijuana stocks too high for an investor tempted to join the party, or do they have room to run? ]]> https://www.proactiveinvestors.com/companies/news/204003/are-marijuana-stocks-too-high-for-an-investor-tempted-to-join-the-party-or-do-they-have-room-to-run-204003.html Fri, 31 Aug 2018 12:51:00 -0400 https://www.proactiveinvestors.com/companies/news/204003/are-marijuana-stocks-too-high-for-an-investor-tempted-to-join-the-party-or-do-they-have-room-to-run-204003.html <![CDATA[News - Small-Cap Snapshot: SAExploration receives court approval to purchase Geokinetics’ assets ]]> https://www.proactiveinvestors.com/companies/news/309923/small-cap-snapshot-saexploration-receives-court-approval-to-purchase-geokinetics-assets-9923.html Fri, 20 Jul 2018 13:56:00 -0400 https://www.proactiveinvestors.com/companies/news/309923/small-cap-snapshot-saexploration-receives-court-approval-to-purchase-geokinetics-assets-9923.html <![CDATA[News - Small-Cap Snapshot: SAExploration receives court approval to purchase Geokinetics’ assets ]]> https://www.proactiveinvestors.com/companies/news/201261/small-cap-snapshot-saexploration-receives-court-approval-to-purchase-geokinetics-assets-201261.html Fri, 20 Jul 2018 10:42:00 -0400 https://www.proactiveinvestors.com/companies/news/201261/small-cap-snapshot-saexploration-receives-court-approval-to-purchase-geokinetics-assets-201261.html <![CDATA[News - Daily CryptoCann Report: Buy a classic car with crypto; WeedMD inks distribution deal in Alberta ]]> https://www.proactiveinvestors.com/companies/news/200237/daily-cryptocann-report-buy-a-classic-car-with-crypto-weedmd-inks-distribution-deal-in-alberta-200237.html Thu, 05 Jul 2018 12:00:00 -0400 https://www.proactiveinvestors.com/companies/news/200237/daily-cryptocann-report-buy-a-classic-car-with-crypto-weedmd-inks-distribution-deal-in-alberta-200237.html <![CDATA[News - Small-Cap Snapshot: Funko introduces a pop culture cereal line with a surprise inside ]]> https://www.proactiveinvestors.com/companies/news/200234/small-cap-snapshot-funko-introduces-a-pop-culture-cereal-line-with-a-surprise-inside-200234.html Thu, 05 Jul 2018 10:55:00 -0400 https://www.proactiveinvestors.com/companies/news/200234/small-cap-snapshot-funko-introduces-a-pop-culture-cereal-line-with-a-surprise-inside-200234.html <![CDATA[News - Zynerba Pharmaceuticals shares sink after unsuccessful trial of cannabis-based skin patch ]]> https://www.proactiveinvestors.com/companies/news/200216/zynerba-pharmaceuticals-shares-sink-after-unsuccessful-trial-of-cannabis-based-skin-patch-200216.html Thu, 05 Jul 2018 08:57:00 -0400 https://www.proactiveinvestors.com/companies/news/200216/zynerba-pharmaceuticals-shares-sink-after-unsuccessful-trial-of-cannabis-based-skin-patch-200216.html <![CDATA[News - Zynerba Pharmaceuticals shares plunge after its net loss in 1Q widens ]]> https://www.proactiveinvestors.com/companies/news/196588/zynerba-pharmaceuticals-shares-plunge-after-its-net-loss-in-1q-widens-196588.html Tue, 08 May 2018 15:36:00 -0400 https://www.proactiveinvestors.com/companies/news/196588/zynerba-pharmaceuticals-shares-plunge-after-its-net-loss-in-1q-widens-196588.html <![CDATA[News - Rovio Entertainment, Angry Birds, Roku and Zynerba Pharmaceuticals - PRE-MARKET ]]> https://www.proactiveinvestors.com/companies/news/184838/rovio-entertainment-angry-birds-roku-and-zynerba-pharmaceuticals-pre-market-184838.html Fri, 29 Sep 2017 07:34:00 -0400 https://www.proactiveinvestors.com/companies/news/184838/rovio-entertainment-angry-birds-roku-and-zynerba-pharmaceuticals-pre-market-184838.html <![CDATA[News - Zynerba Pharmaceuticals shares tank after disappointing epilepsy trial results ]]> https://www.proactiveinvestors.com/companies/news/182065/zynerba-pharmaceuticals-shares-tank-after-disappointing-epilepsy-trial-results-182065.html Mon, 07 Aug 2017 08:54:00 -0400 https://www.proactiveinvestors.com/companies/news/182065/zynerba-pharmaceuticals-shares-tank-after-disappointing-epilepsy-trial-results-182065.html <![CDATA[News - Zynerba Pharma to highlight data to American Epilepsy Society ]]> https://www.proactiveinvestors.com/companies/news/169614/zynerba-pharma-to-highlight-data-to-american-epilepsy-society-169614.html Mon, 28 Nov 2016 09:03:00 -0500 https://www.proactiveinvestors.com/companies/news/169614/zynerba-pharma-to-highlight-data-to-american-epilepsy-society-169614.html <![CDATA[News - Zynerba doses first patient in epilepsy gel trial ]]> https://www.proactiveinvestors.com/companies/news/128853/zynerba-doses-first-patient-in-epilepsy-gel-trial-128853.html Mon, 01 Aug 2016 09:27:00 -0400 https://www.proactiveinvestors.com/companies/news/128853/zynerba-doses-first-patient-in-epilepsy-gel-trial-128853.html